Astrocytes Enhance the Invasion Potential of Glioblastoma Stem-Like Cells

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Rath, Barbara H ^a   Fair, Joshlean M ^a   Jamal, Muhammad ^a   Camphausen, Kevin ^a   Tofilon, Philip J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN;

ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL MOTION; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ASSOCIATION; GLIOBLASTOMA; GLIOBLASTOMA STEM LIKE CELL; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOLAYER CULTURE; NEURAL STEM CELL; PROGENY; TUMOR MICROENVIRONMENT;

ANTIGENS, CD; ASTROCYTES; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; MICROSCOPY, ELECTRON, SCANNING TRANSMISSION; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PEPTIDES; TRANSCRIPTOME; TUMOR MICROENVIRONMENT;

EID: 84872790252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054752     Document Type: Article

References (50)

1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466.
2. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
3. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, et al. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021.
4. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
5. Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, et al. (2011) Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun 406: 643-648.
6. Tower DB, Young OM, (1973) The activities of butyrylcholinesterase and carbonic anhydrase, the rate of anaerobic glycolysis, and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale. J Neurochem 20: 269-278.
7. Garcia-Segura LM, McCarthy MM, (2004) Minireview: Role of glia in neuroendocrine function. Endocrinology 145: 1082-1086.
8. Aloisi F, Borsellino G, Care A, Testa U, Gallo P, et al. (1995) Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain. Int J Dev Neurosci 13: 265-274.
9. Sofroniew MV, Vinters HV, (2010) Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35.
10. Chen Y, Swanson RA, (2003) Astrocytes and brain injury. J Cereb Blood Flow Metab 23: 137-149.
11. Ethell IM, Ethell DW, (2007) Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 85: 2813-2823.
12. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG, (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36: 1046-1069.
13. McCord AM, Jamal M, Shankavaram UT, Lang FF, Camphausen K, et al. (2009) Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res 7: 489-497.
14. McCord AM, Jamal M, Williams ES, Camphausen K, Tofilon PJ, (2009) CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin Cancer Res 15: 5145-5153.
15. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, et al. (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4: 568-580.
16. Shaw LM, (2005) Tumor cell invasion assays. Methods Mol Biol 294: 97-105.
17. Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, et al. (2011) Inflammatory mediators in breast cancer: coordinated expression of TNFalpha & IL-1beta with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer 11: 130.
18. Chetty C, Vanamala SK, Gondi CS, Dinh DH, Gujrati M, et al. (2012) MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cell Signal 24: 549-559.
19. de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, et al. (2010) Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A 107: 6340-6345.
20. Tatenhorst L, Rescher U, Gerke V, Paulus W, (2006) Knockdown of annexin 2 decreases migration of human glioma cells in vitro. Neuropathol Appl Neurobiol 32: 271-277.
21. Udabage L, Brownlee GR, Waltham M, Blick T, Walker EC, et al. (2005) Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res 65: 6139-6150.
22. Sen S, Dong M, Kumar S, (2009) Isoform-specific contributions of alpha-actinin to glioma cell mechanobiology. PLoS One 4: e8427.
23. Rodrigues-Ferreira S, Abdelkarim M, Dillenburg-Pilla P, Luissint AC, di-Tommaso A, et al. (2012) Angiotensin II facilitates breast cancer cell migration and metastasis. PLoS One 7: e35667.
24. Udabage L, Brownlee GR, Nilsson SK, Brown TJ, (2005) The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res 310: 205-217.
25. Kohutek ZA, diPierro CG, Redpath GT, Hussaini IM, (2009) ADAM-10-mediated N-cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration. J Neurosci 29: 4605-4615.
26. Liu Q, Li G, Li R, Shen J, He Q, et al. (2010) IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol 100: 165-176.
27. Slack-Davis JK, Atkins KA, Harrer C, Hershey ED, Conaway M, (2009) Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res 69: 1469-1476.
28. Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, et al. (2008) Glioma cells on the run- the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 9: 54.
29. Wick W, Grimmel C, Wild-Bode C, Platten M, Arpin M, et al. (2001) Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. J Neurosci 21: 3360-3368.
30. Ehtesham M, Winston JA, Kabos P, Thompson RC, (2006) CXCR4 expression mediates glioma cell invasiveness. Oncogene 25: 2801-2806.
31. Wang D, Yamamoto S, Hijiya N, Benveniste EN, Gladson CL, (2000) Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions. Oncogene 19: 5801-5809.
32. Seike T, Fujita K, Yamakawa Y, Kido MA, Takiguchi S, et al. (2011) Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis. Clin Exp Metastasis 28: 13-25.
33. Son MJ, Woolard K, Nam DH, Lee J, Fine HA, (2009) SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4: 440-452.
34. Friedl P, Alexander S, (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147: 992-1009.
35. Kim SJ, Kim JS, Park ES, Lee JS, Lin Q, et al. (2011) Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia 13: 286-298.
36. Lin Q, Balasubramanian K, Fan D, Kim SJ, Guo L, et al. (2010) Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. Neoplasia 12: 748-754.
37. Hoelzinger DB, Demuth T, Berens ME, (2007) Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99: 1583-1593.
38. Jan HJ, Lee CC, Shih YL, Hueng DY, Ma HI, et al. (2010) Osteopontin regulates human glioma cell invasiveness and tumor growth in mice. Neuro Oncol 12: 58-70.
39. Jones TS, Holland EC (2011) Standard of care therapy for malignant glioma and its effect on tumor and stromal cells. Oncogene.
40. Marcus HJ, Carpenter KL, Price SJ, Hutchinson PJ, (2010) In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines. J Neurooncol 97: 11-23.
41. Liang Y, Bollen AW, Gupta N, (2008) CC chemokine receptor-2A is frequently overexpressed in glioblastoma. J Neurooncol 86: 153-163.
42. Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang XP, et al. (2006) SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett 236: 39-45.
43. Song SW, Fuller GN, Khan A, Kong S, Shen W, et al. (2003) IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci U S A 100: 13970-13975.
44. Esencay M, Newcomb EW, Zagzag D, (2010) HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration. J Neurooncol 99: 33-40.
45. Anido J, Saez-Borderias A, Gonzalez-Junca A, Rodon L, Folch G, et al. (2010) TGF-beta Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell 18: 655-668.
46. Mohanam S, Wang SW, Rayford A, Yamamoto M, Sawaya R, et al. (1995) Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin Exp Metastasis 13: 57-62.
47. Aaberg-Jessen C, Christensen K, Offenberg H, Bartels A, Dreehsen T, et al. (2009) Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival. J Neurooncol 95: 117-128.
48. Vajkoczy P, Knyazev P, Kunkel A, Capelle HH, Behrndt S, et al. (2006) Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci U S A 103: 5799-5804.
49. Folkins C, Shaked Y, Man S, Tang T, Lee CR, et al. (2009) Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res 69: 7243-7251.
50. Edwards LA, Woolard K, Son MJ, Li A, Lee J, et al. (2011) Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst 103: 1162-1178.